The effect of the Mirror Effect Plus protocol in acute Bell's palsy
- Conditions
- Acute Bell's palsyNervous System DiseasesBell palsy
- Registration Number
- ISRCTN93896690
- Lead Sponsor
- Centres Intégré Universitaires de Santé et de Services Sociaux
- Brief Summary
2022 Results article in https://doi.org/10.1177%2F02692155221107090 (added 18/07/2022)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 40
1. Aged 18 years and older
2. First episode of Bell's Palsy
3. Having persistent severe Bell's palsy 10 days post-onset
4. Received the recommended drug regimen for severe and total BP (1000 mg valacyclovir three times daily for 7 days and 50 mg prednisone once daily for 10 days) began within 72 hours of onset
5. Normal cognitive status based on the Montreal Cognitive Assessment
1. History of trauma to the 7th cranial nerve
2. Having suffered from Bell's palsy previously or any other facial palsy of another origin (e.g. secondary to surgery or a syndrome
3. History of neurological disorders (e.g. stroke, neurodegenerative diseases)
4. Psychiatric illness on active treatment (e.g. schizophrenia, severe depression)
5. History of neoplastic diseases
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of facial palsy assessed using the Facial Nerve Grading System 2.0 (FNGS 2.0; also known as the House-Brackmann 2.0 score and the Sunnybrook Facial Grading System at the initial assessment (10 to 14 days after onset) as well as 1, 2, 3, 4, 5, 6 and 12 months after onset
- Secondary Outcome Measures
Name Time Method Speech intelligibility measured using a visual analog scale at the initial assessment (10 to 14 days after onset) as well as 1, 2, 3, 4, 5, 6 and 12 months after onset